HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel integrin antagonists derived from thrombospondins.

Abstract
Specific antagonists have been successfully developed for several different integrins. Clinical trials have been initiated to study therapeutic uses of these inhibitors in cancer, thrombosis, and inflammatory diseases. Most efforts to date have focused on the platelet integrin alphaIIbbeta3, endothelial alphavbeta3, and the leukocyte integrin alpha4beta1. However, the integrin family contains additional members with interesting tissue specificities and functional properties that could also be useful molecular targets for disease intervention. In many cases, specific recognition motifs for these integrins have not been identified, which has precluded development of specific antagonists. Our recent studies of thrombospondin-1 and thrombospondin-2 recognition by integrins have revealed novel motifs for alpha3beta1 and alpha6beta1 integrins as well as new motifs recognized by the well studied alpha4beta1 integrin. These three integrins play distinct roles in angiogenesis and its modulation by thrombospondins. This review will discuss recent insights into the specificities of alpha3beta1 and alpha6beta1 integrins, their functions in angiogenesis, and potential applications for antagonists of these integrins and of alpha4beta1 to control pathological angiogenesis and other diseases.
AuthorsMaria J Calzada, David D Roberts
JournalCurrent pharmaceutical design (Curr Pharm Des) Vol. 11 Issue 7 Pg. 849-66 ( 2005) ISSN: 1381-6128 [Print] United Arab Emirates
PMID15777239 (Publication Type: Journal Article, Review)
Chemical References
  • Angiogenesis Inhibitors
  • CD36 Antigens
  • Integrins
  • Thrombospondins
Topics
  • Amino Acid Sequence
  • Angiogenesis Inhibitors (pharmacology)
  • Animals
  • Binding Sites
  • CD36 Antigens (drug effects)
  • Humans
  • Integrins (antagonists & inhibitors)
  • Neovascularization, Physiologic (drug effects, physiology)
  • Protein Binding
  • Thrombospondins (chemistry, pharmacology, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: